Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BY 4.0Frontiers in Pharmacology

Nrf2-related pathogenesis of premature ovarian insufficiency and traditional Chinese medicine-based interventions

Abstract

Premature ovarian insufficiency (POI) is a complex reproductive disorder characterized by diminished ovarian reserve and impaired ovarian endocrine function before the age of 40 years. Increasing evidence indicates that oxidative stress plays a pivotal role in POI pathogenesis by inducing mitochondrial dysfunction, DNA damage, inflammatory responses, ferroptosis, and granulosa cell apoptosis, ultimately accelerating follicular depletion. Nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of cellular antioxidant defense, is essential for maintaining ovarian redox homeostasis and protecting reproductive function. Recent advances have demonstrated that traditional Chinese medicine (TCM), including herbal medicines, bioactive metabolites, classical formulations, and acupuncture therapies, exerts protective effects against POI by modulating Nrf2-associated signaling networks, thereby enhancing antioxidant enzyme expression, improving mitochondrial function, reducing oxidative DNA damage, suppressing inflammation and apoptosis, and preserving follicular development. This review summarizes the pathological role of oxidative stress and Nrf2 signaling in POI, and discusses the current progress of TCM interventions modulating the Nrf2 pathway, including their molecular mechanisms and therapeutic potential. Furthermore, the limitations of current research, including the lack of clinically representative models, limited understanding of molecular targets, and insufficient evidence from well-designed clinical studies, are highlighted. Future studies integrating multi-omics approaches, precision medicine, and evidence-based clinical trials are warranted to further elucidate the regulatory networks of TCM-mediated Nrf2 activation and promote the clinical translation of TCM strategies for POI prevention and treatment.

Related

  1. Screening traditional Chinese medicine monomers for premature ovarian insufficiency: from network meta-analysis to the effects of a promising candidate on oxidative stress biomarkers
    Yanping Tan, Mei Zhao, Lianwei Xu
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. Genetics of Premature Ovarian Insufficiency: From Molecular Architecture to Precision Medicine.
    Vanessa Sousa, Gabriel Livera, Micheline Misrahi
    International journal of molecular sciencesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  3. Macrophage lipophagy in atherosclerosis: from molecular mechanisms to traditional Chinese medicine interventions
    Ying Hu, Shuo Yuan, Xingjuan Chen +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCEurope PMCPMC
  4. Traditional Chinese medicine interventions and mitochondrial communication in myocardial and cerebral ischemia: a critical review
    Zhijie Wan, Xinyue Wang, Ziqiong Xu +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  5. Non-pharmacological traditional Chinese medicine interventions for depression: bibliometric mapping of Chinese databases and WoSCC, 2000-2025.
    Sihan Dong, Yazhen Lian, Jiahui Xie +4
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{li2026nrf2related,
  title = {{Nrf2-related pathogenesis of premature ovarian insufficiency and traditional Chinese medicine-based interventions}},
  author = {Lan Li and Xinwu Zheng and Meiqiao Wang and Kaifeng Yang and Bin Zhou},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = nov,
  doi = {10.3389/fphar.2026.1958737},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1958737},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Nrf2-related pathogenesis of premature ovarian insufficiency and traditional Chinese medicine-based interventions
AU  - Lan Li
AU  - Xinwu Zheng
AU  - Meiqiao Wang
AU  - Kaifeng Yang
AU  - Bin Zhou
PY  - 2026
DA  - 2026/11/09
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1958737
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1958737
AB  - Premature ovarian insufficiency (POI) is a complex reproductive disorder characterized by diminished ovarian reserve and impaired ovarian endocrine function before the age of 40 years. Increasing evidence indicates that oxidative stress plays a pivotal role in POI pathogenesis by inducing mitochondrial dysfunction, DNA damage, inflammatory responses, ferroptosis, and granulosa cell apoptosis, ultimately accelerating follicular depletion. Nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of cellular antioxidant defense, is essential for maintaining ovarian redox homeostasis and protecting reproductive function. Recent advances have demonstrated that traditional Chinese medicine (TCM), including herbal medicines, bioactive metabolites, classical formulations, and acupuncture therapies, exerts protective effects against POI by modulating Nrf2-associated signaling networks, thereby enhancing antioxidant enzyme expression, improving mitochondrial function, reducing oxidative DNA damage, suppressing inflammation and apoptosis, and preserving follicular development. This review summarizes the pathological role of oxidative stress and Nrf2 signaling in POI, and discusses the current progress of TCM interventions modulating the Nrf2 pathway, including their molecular mechanisms and therapeutic potential. Furthermore, the limitations of current research, including the lack of clinically representative models, limited understanding of molecular targets, and insufficient evidence from well-designed clinical studies, are highlighted. Future studies integrating multi-omics approaches, precision medicine, and evidence-based clinical trials are warranted to further elucidate the regulatory networks of TCM-mediated Nrf2 activation and promote the clinical translation of TCM strategies for POI prevention and treatment.
SN  - 1663-9812
ER  -